Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease

Abstract Background Several studies have shown that patients with anti-MDA5 antibody-positive dermatomyositis (anti-MDA5 antibody + DM) have an increased risk of developing rapid progression of interstitial lung disease (RPILD), which is associated with poor prognosis and high mortality. However, di...

Full description

Bibliographic Details

Published in:	Arthritis Research & Therapy
Main Authors:	Kaikai Zhao, Juan Zhang, Qunyu Kong, Yong Zhang, Cong Li, Kaikai Huo, Na Fan, Wenjing Deng, Jie Shi, Chunya Wang, Xueyi Li, Shuanying Yang, Ping Fang
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Subjects:	Anti-MDA5 antibody Dermatomyositis Interstitial lung disease Prognostic factors
Online Access:	https://doi.org/10.1186/s13075-025-03485-z